Advertisement

Topics

Highmark Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 04082017] Prices from USD $175

04:32 EDT 31 Aug 2017 | BioPortfolio Reports

Highmark Inc. Strategy, SWOT and Corporate Finance Report

Summary

Highmark Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Highmark Inc. Highmark or 'the company' is a privatelyheld nonprofit health insurance company in the US. The company is headquartered in Pittsburgh, Pennsylvania, and employs about 20,000 people.

Scope

Detailed information on Highmark Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Highmark Inc. in the form of a SWOT analysis
An indepth view of the business model of Highmark Inc. including a breakdown and examination of key business segments
Intelligence on Highmark Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Highmark Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Highmark Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Highmark Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Highmark Inc.'s business structure, strategy and prospects.

Original Article: Highmark Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 04082017] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Highmark Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 04082017] Prices from USD $175"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...